Thymosin beta-4 Completed Phase 2 Trials for Dry Eye Syndrome (DES) / Dry Eyes Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01387347
Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye